Fiona Marshall is VP Head of the UK Discovery Centre for MSD Research Laboratories. She was previously Chief Scientific Officer and founder of Heptares Therapeutics, which was spun out from the MRC Laboratory of Molecular Biology, and later sold to Sosei Group.
Fiona has a BSc in biochemistry from the University of Bath and a PhD in neuroscience from the University of Cambridge. She has more than 25 years' experience as an entrepreneur and in drug discovery, which included senior positions at GSK and Millennium Pharmaceuticals. Fiona is also recognised for her expertise in the field of G-protein coupled receptors (GPCRs) and has published extensively in this field.
Fiona is on the Council of the Academy of Medical Sciences and on translational advisory boards of the MRC, the Francis Crick Institute and Wellcome Trust. She won the 2012 WISE Women of Outstanding Achievement for Innovation and Entrepreneurship and the 2015 RSC Malcolm Campbell Award for chemistry.